13F

MIRM MIRUM PHARMACEUTICALS INC

2026Q1 · CUSIP 604749101 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
309
Δ holders QoQ
+25
Breadth percentile
Top 12%
Whale holders
152
Δ whales
+7
Inst. holding value
$6.3B
New positions
67
Closed positions
42
Price momentum (1Q)
-7.1%
Put / Call
3/4

Breadth history (34 quarters)

2019Q4: Δ+2 · h=41 2020Q1: Δ+3 · h=44 2020Q2: Δ+15 · h=59 2020Q3: Δ-7 · h=52 2020Q4: Δ+22 · h=74 2021Q1: Δ-11 · h=63 2021Q2: Δ+6 · h=69 2021Q3: Δ+5 · h=74 2021Q4: Δ+11 · h=85 2022Q1: Δ+13 · h=98 2022Q2: Δ+11 · h=109 2022Q3: Δ+5 · h=114 2022Q4: Δ-10 · h=104 2023Q1: Δ+14 · h=118 2023Q2: Δ+30 · h=148 2023Q3: Δ+12 · h=160 2023Q4: Δ+28 · h=188 2024Q1: Δ-16 · h=172 2024Q2: Δ-10 · h=162 2024Q3: Δ+17 · h=179 2024Q4: Δ+28 · h=207 2025Q1: Δ+9 · h=216 2025Q2: Δ+1 · h=217 2025Q3: Δ+56 · h=273 2025Q4: Δ+11 · h=284 2026Q1: Δ+25 · h=309 2019Q4: holders=41 2020Q1: holders=44 2020Q2: holders=59 2020Q3: holders=52 2020Q4: holders=74 2021Q1: holders=63 2021Q2: holders=69 2021Q3: holders=74 2021Q4: holders=85 2022Q1: holders=98 2022Q2: holders=109 2022Q3: holders=114 2022Q4: holders=104 2023Q1: holders=118 2023Q2: holders=148 2023Q3: holders=160 2023Q4: holders=188 2024Q1: holders=172 2024Q2: holders=162 2024Q3: holders=179 2024Q4: holders=207 2025Q1: holders=216 2025Q2: holders=217 2025Q3: holders=273 2025Q4: holders=284 2026Q1: holders=309 -56 -28 +0 +28 +56 36181325 19Q420Q321Q222Q122Q423Q324Q225Q125Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 11 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 12%
2025Q3 Top 4% +46.1% +34.3%
2024Q4 Top 19% -14.8% +23.6%
2024Q3 Top 20% +26.6% +6.3%
2023Q4 Top 19% -17.8% +42.9%
2023Q3 Top 15% -4.0% -16.5%
2023Q2 Top 6% +22.8% +17.3%
2023Q1 Top 12% -5.9% +16.0%

Options Sentiment

Put holders
3
QoQ: +1
Call holders
4
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
EPS (TTM)
$-13.60
EPS YoY
Revenue (TTM)
$0.6B
Revenue YoY
+50.2%
Quarterly Revenue & EPS (4Y)
2022-06-30: $17M 2022-09-30: $19M 2022-12-31: $28M 2023-03-31: $32M 2023-06-30: $37M 2023-09-30: $48M 2023-12-31: $70M 2024-03-31: $69M 2024-06-30: $78M 2024-09-30: $90M 2024-12-31: $99M 2025-03-31: $112M 2025-06-30: $128M 2025-09-30: $133M 2025-12-31: $149M 2026-03-31: $160M 2022-06-30: EPS -0.84 2022-09-30: EPS -1.02 2022-12-31: EPS -0.99 2023-03-31: EPS -0.80 2023-06-30: EPS -1.94 2023-09-30: EPS -0.57 2023-12-31: EPS -0.69 2024-03-31: EPS -0.54 2024-06-30: EPS -0.52 2024-09-30: EPS -0.30 2024-12-31: EPS -0.49 2025-03-31: EPS -0.30 2025-06-30: EPS -0.12 2025-09-30: EPS 0.05 2025-12-31: EPS -0.10 2026-03-31: EPS -13.43 0M 80M 160M $M -14.77 -7.36 0.06 20222023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

As of 2026-03-31 · SEC filings (XBRL)